These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5924119)

  • 1. Pyrimidine derivatives. 8. 5-Arylazopyrimidines and their inhibitory effects against transplantable mouse tumors.
    Israel M; Schlein HN; Maddock CL; Farber S; Modest EJ
    J Pharm Sci; 1966 Jun; 55(6):568-72. PubMed ID: 5924119
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines.
    Hampshire J; Hebborn P; Triggle AM; Triggle DJ; Vickers S
    J Med Chem; 1965 Nov; 8(6):745-9. PubMed ID: 5885064
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibility of potentiating the antineoplastic effect of a folic acid antagonist by methylcobalamin analogs].
    Sof'ina ZP; Miasishcheva NV; Arsenian FG; Iurkevich AM
    Vestn Akad Med Nauk SSSR; 1979; (1):72-8. PubMed ID: 419866
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylenic carbamates. A new class of potential oncolytic agents.
    Dillard RD; Poore G; Cassady DR; Easton NR
    J Med Chem; 1967 Jan; 10(1):40-4. PubMed ID: 5233161
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of potential antineoplastic agents. XIV. Some 2-substituted 2,3-dihydro-1h-perimidines.
    Wasulko W; Noble AC; Popp FD
    J Med Chem; 1966 Jul; 9(4):599-601. PubMed ID: 4165378
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
    Mihich E; Gelzer J
    Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of L-dopa, noradrenalin and adrenalin on P-388 mouse leukemia, B-16 mouse melanoma and E 0771 mammary carcinoma.
    Shohat B; Kott E; Bornstein B
    Experientia; 1975 Jan; 31(1):110-1. PubMed ID: 1112301
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents.
    Gangjee A; Shi J; Queener SF; Barrows LR; Kisliuk RL
    J Med Chem; 1993 Oct; 36(22):3437-43. PubMed ID: 8230134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors.
    Shimizu F; Arakawa M
    Gan; 1978 Aug; 69(4):545-8. PubMed ID: 710804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of potential antineoplastic agents. XV. Some l,4-bisamides of 1,2,3,4-tetrahydroquinoxaline.
    Schuyler P; Popp FD; Noble AC; Alwani DW; Masters BR
    J Med Chem; 1966 Sep; 9(5):704-7. PubMed ID: 6007964
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucan:inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models.
    Di Luzio NR; McNamee R; Browder WI; Williams D
    Cancer Treat Rep; 1978 Nov; 62(11):1857-66. PubMed ID: 728903
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of structure to antitumor activity in compounds related to folic acid.
    Mead JA; Wood HB; Goldin A
    Cancer Chemother Rep 2; 1968 Nov; 1(2):273-361. PubMed ID: 5732302
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative determination of the effect of antineoplastic agents].
    Brius VR
    Probl Gematol Pereliv Krovi; 1975 Jul; 20(7):33-8. PubMed ID: 1197231
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening data from the cancer chemotherapy National Service Center Screening Laboratories. XLV.
    Schepartz SA; Abbott BJ; Leiter J
    Cancer Res; 1967 Nov; 27(11 Pt 2):1115-283. PubMed ID: 4294535
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isobutyl N-chloroethyl-N-nitrosocarbamate.
    Ross WC
    J Med Chem; 1967 Jan; 10(1):108-9. PubMed ID: 6031685
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of possible cancer chemotherapeutic agents based on enzyme rationale. VI. Allylamine derivatives.
    Tsou KC; Damle SB; Crichlow RW; Ravdin RG; Blunt HW
    J Pharm Sci; 1967 Apr; 56(4):484-8. PubMed ID: 6034545
    [No Abstract]   [Full Text] [Related]  

  • 18. 1,3,2-diazaphosphorine 2-oxides. 3. Preparation and biological evaluation of some 1,3-bis(aralkyl)-2-halo-1,3,2-diazaphosphorine 2-oxides and related compounds.
    Billman JH; Meisenheimer JL; May RF
    J Med Chem; 1966 Sep; 9(5):772-4. PubMed ID: 4291025
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and biological activity of 9-beta-D-ribofuranosyl-6-hydroxylaminopurine.
    Giner Sorolla A; Medrek L; Bendich A
    J Med Chem; 1966 Jan; 9(1):143-4. PubMed ID: 5226633
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
    Kuśnierczyk H; Radzikowski C; Paprocka M; Budzyński W; Rak J; Kinas R; Misiura K; Stec W
    J Immunopharmacol; 1986; 8(4):455-80. PubMed ID: 3805744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.